| Filed On | Filing |
|---|---|
| 21 May 2021 |
8-K/A: Financial Statements and Exhibits
Report of Independent Auditor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F-2 |
| 26 Feb 2020 |
8-K/A: Financial Statements and Exhibits
We hereby consent to the incorporation by reference in the Registration Statements (Form S-1 Nos 333-207421, 333-205414, 333-209874, 333-212100, 333-213489, 333-220351, Form S-3 Nos 333-221735, 333-235548, and Form S-8 No. 333-205462) of... |
| 10 Jan 2020 |
8-K/A: Completion of Acquisition or Disposition of Assets
The following unaudited pro forma condensed combined financial information is presented to illustrate the estimated effects of the merger. |
| 07 Nov 2019 |
8-K/A: Entry into a Material Definitive Agreement
This Consent and Limited Waiver Agreement (this “Waiver”) is entered into as of the November 1, 2019, by and among Peter Steelman (“Steelman”), James Flynn (“Flynn”), and Deerfield CSF, LLC, on behalf of itself and its affiliates (“Deerf... |
| 04 Nov 2019 |
8-K/A: Financial Statements and Exhibits
This Consent and Limited Waiver Agreement (this “Waiver”) is entered into as of the November 1, 2019, by and among Peter Steelman (“Steelman”), James Flynn (“Flynn”), and Deerfield CSF, LLC, on behalf of itself and its affiliates (“Deerf... |
| 31 Aug 2017 |
8-K/A: Results of Operations and Financial Condition
Englewood, CO – August 31, 2017 – Aytu BioScience, Inc. (OTCQX: AYTUD), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an overview of its business, includin... |
| 20 Jul 2017 |
8-K/A: Financial Statements and Exhibits
As of March 31, 2017, and for the Nine Month Period Ended March 31, 2017 |
| 30 Jul 2015 |
8-K/A: Financial Statements and Exhibits
On May 20, 2015 Aytu BioScience, Inc. (the “Company”) (formerly Rosewind Corporation) consummated the previously announced purchase of certain assets and rights associated with ProstaScint® (the “Product”), and the sourcing, manufacture ... |
| 08 Jun 2015 |
8-K/A: Other Events
*** CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATIO... |
Loading...